Podogigants A and B, two new potentiators of amphotericin B activity, from Sordariomycete Podostroma giganteum

J Nat Med. 2021 Sep;75(4):877-883. doi: 10.1007/s11418-021-01531-z. Epub 2021 May 16.

Abstract

Two new compounds, podogigants A (1) and B (2), were isolated from the culture broth of Podostroma giganteum. This is the first report on the identification of secondary metabolites in P. giganteum. The structures of 1 and 2 were elucidated through spectroscopic analysis, including 2D NMR spectroscopy assisted by chemical derivatization, which revealed the presence of farnesyl- and geranyl-hydroquinone structures, respectively. Compounds 1 and 2 exhibited no antifungal activity even at a concentration of 64 μg/mL, whereas they potentiated amphotericin B (AmB) activity against several species of fungi. In particular, 1 potentiated AmB activity against C. albicans and R. oryzae by up to 32-fold (MIC value of AmB decreased from 1.0 to 0.032 µg/mL), while 2 potentiated AmB activity against C. albicans by up to 16-fold.

Keywords: Amphotericin B; Candida albicans; Podogigants A and B; Podostroma giganteum; Potentiator; Sordariomycete.

MeSH terms

  • Amphotericin B* / pharmacology
  • Antifungal Agents* / pharmacology
  • Candida albicans
  • Microbial Sensitivity Tests

Substances

  • Antifungal Agents
  • Amphotericin B